US FDA approves Merck immunotherapy/chemo combo for lung cancer – Reuters
Reuters |
US FDA approves Merck immunotherapy/chemo combo for lung cancer
Reuters A view of the Merck & Co. campus in Linden, New Jersey March 9, 2009, after Merck & Co Inc said it would acquire Schering-Plough Corp in $41.1 billion deal, widening Merck's pipeline and diversifying its portfolio of medicines. REUTERS/Jeff Zelevansky. Merck Extends Immunotherapy Lead With Lung Cancer Combination Therapy Approval FDA approves Merck immunotherapy/chemo combo for lung cancer FDA Approves Keytruda Combo for Lung Cancer |
